Abstract
Immunoreactive prolactin-like material (Ir Prl) was detected in urines of eugonadal women during the luteal phase and in urines of pregnant and lactating women. The levels of Ir Prl urinary excretion per 24 h and of elimination per 100 ml of glomerular filtrate were highest in lactating women as compared to pregnant women; levels in pregnant women were elevated as compared to eugonadal subjects. Iv injection of thyrotropin releasing hormone (TRH, 200 μg) caused increased levels of urinary Ir Prl. The physicochemical characteristics of urinary Ir Prl of lactating women were investigated by filtrating urine samples on Ultragel Aca 54 in presence or absence of Trasylol. Urines, supplemented with Trasylol and analyzed either immediately or after storage at room temperature for 24 h, contained in addition to the 23,000 Mr monomeric form (25.2+7.4%), two fractions of high (≥ 70,000) or low (< 23,000) molecular weight, respectively. The latter material largely predominated (73.5±7.3%). Urines kept at room temperature for 24 h without Trasylol showed variable but significant decreases in the monomer form with a parallel increase in high MW and fragmented forms. The extent of degradation of the monomer was directly proportional to the proteolytic activity of the urines as estimated by the Azocoll breakdown test. Contrary to what was observed with the urinary endogenous monomeric Prl, human pituitary Prl.remained unaltered upon incubation in Trasylol-free urines up to 45 h. These experiments suggest that Prl when it is excreted in the urine, undergoes varying modifications which give rise to immunoreactive aggregates, fragments and a material of normal molecular weight but of high sensitivity to the action of the urinary proteases.
Similar content being viewed by others
References
Garnier P.E., Aubert M.L., Kaplan S.L., Grumbach H.M. Heterogeneity of pituitary and plasma prolactin in man: decreased affinity of “big prolactin” in a radioreceptor assay and evidence for its secretion. J. Clin. Endocrinol. Metab. 47: 1273, 1978.
Suh H.K., Frantz A.G. Size heterogeneity of human prolactin in plasma and pituitary extracts. J. Clin. Endocrinol. Metab. 39: 928, 1974.
Friesen H.G. Prolactin determination by radioimmunoreceptor and bioassays. Proceedings of the 3rd International Meeting on human prolactin, Athènes, October 1981.
Rogol A.D., Rosen S.W. Prolactin of apparent large molecular size: the major immunoreactive prolactin component in plasma of a patient with a pituitary tumor. J. Clin. Endocrinol. Metab. 38: 714, 1974.
Suh H.K., Frantz A.G. Big and little prolactin in human plasma. Clin. Res. 21: 960, 1973.
Guyda H.J., Whyte S. Big prolactin (bPRL): “in vitro” secretion and radioreceptor activity (RRA) in serum. Clin. Res. 22: 341, 1974.
Guyda H.J. Heterogeneity of human growth hormone and prolactin secreted “in vitro”: immunoassay and radioreceptor assay correlations. J. Clin. Endocrinol. Metab. 41: 953, 1975.
Kataoka K., Imai Y., Hollander C.S. Altered heterogeneity of circulating prolactin following thyrotropin releasing hormone. Clin. Res. 23: 238, 1975.
Whitaker M.D., Klee G.G., Kao P.C., Randall R.V., Heser D.W. Demonstration of biological activity of prolactin molecular weight variants in human sera. J. Clin. Endocrinol. Metab. 58: 826, 1983.
Gala R.R., Singhakowinta A., Brennan M.J. Studies on prolactin in human serum, urine and milk. Horm. Res. 6: 310, 1975.
Sinha Y.N., Selby F.W., Vanderlaan W.P. Radioimmunoassay of prolactin in the urine of mouse and man. J. Clin. Endocrinol. Metab. 36: 1039, 1973.
Goldhaber G., Shani J. Direct radioimmunoassay of human prolactin in semen, serum and urine. J. Endocrinol. 72: 391, 1977.
Reuter A.M., Kennes F., Vrindts-Gevaert Y., Franchimont P. Homologous radioimmunoassay for human prolactin. Int.J. Nucl. Med. Biol. 3: 21, 1976.
Franchimont P., Hendrick J.C., Bourguignon J.P., Reuter A.M. Pitfalls in peptide radioimmunoassays. In: Odell W.D., Franchimont P. (Eds.), Principles of competitive protein-binding assays. John Wiley and Sons, New York, 1981, p. 149.
Cooper D.S., Ridgway E.C., Kliman B., Kjellberg R.N., Maloof F. Metabolic clearance and production rate of prolactin in man. J.Clin. Invest. 64: 1669, 1979.
Falconer I.R., Vacek A.T. Degradation of prolactin by the mammalian kidney. In: Tolis G., Stefanis C., Mountokalakis T., Labrie F. (Eds.), Prolactin and prolactinomas. Raven Press, New York, 1983, p. 231.
Lim V.S., Frohman L.A. Pathogenesis of hyperprolactinemia in chronic renal failure. In: In: Tolis G., Stefanis C., Mountokalakis T., Labrie F. (Eds.), Prolactin and prolactinomas. Raven Press, New York, 1983, p. 265.
Author information
Authors and Affiliations
Additional information
This work is supported by grant no. 3.4501.80 from Belgian Foundation for Medical Research (F.R.S.M.)
Rights and permissions
About this article
Cite this article
Ghuysen, V., Van Cauwenberge, J.R., Reuter, A. et al. Immunoreactive prolactin like material in the urine of women. J Endocrinol Invest 8, 349–355 (1985). https://doi.org/10.1007/BF03348512
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348512